20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with 3,5-dihydroxyphenylglycine in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (3,5-dihydroxyphenylglycine) | Trials (3,5-dihydroxyphenylglycine) | Recent Studies (post-2010) (3,5-dihydroxyphenylglycine) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 301 | 1 | 61 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falck, JR; Gebremedhin, D; Hammock, BD; Harder, DR; Hwang, SH; Koehler, RC; Li, C; Liu, X; Roman, RJ | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and 3,5-dihydroxyphenylglycine
| Article | Year |
|---|---|
Epoxyeicosatrienoic acid-dependent cerebral vasodilation evoked by metabotropic glutamate receptor activation in vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Arterioles; Blood Flow Velocity; Cerebral Arteries; Cerebral Cortex; Cerebrovascular Circulation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Epoxide Hydrolases; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Heme Oxygenase (Decyclizing); Hydroxyeicosatetraenoic Acids; Laser-Doppler Flowmetry; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Wistar; Receptor, Adenosine A2B; Receptors, Metabotropic Glutamate; Regional Blood Flow; Resorcinols; Signal Transduction; Time Factors; Vasodilation; Vasodilator Agents | 2011 |